AG000IKU

119302-91-9 | Pyrrolidinium, 1-[(2β,3α,5α,16β,17β)-17-(acetyloxy)-3-hydroxy-2-(4-morpholinyl)androstan-16-yl]-1-(2-propenyl)-, bromide

Chemical structure of Pyrrolidinium, 1-[(2β,3α,5α,16β,17β)-17-(acetyloxy)-3-hydroxy-2-(4-morpholinyl)androstan-16-yl]-1-(2-propenyl)-, bromide, CAS 119302-91-9
AG000IKU
sdsSDS
sdsCOA
TIP This product is typically in stock.Please contact us for quotation.
Request For Quotation

CAS Number 119302-91-9
Catalog Number AG000IKU(AGN-PC-0PD4ZF)
Chemical Name Pyrrolidinium, 1-[(2β,3α,5α,16β,17β)-17-(acetyloxy)-3-hydroxy-2-(4-morpholinyl)androstan-16-yl]-1-(2-propenyl)-, bromide
EC Number 601-597-6
IUPAC Name [(2S,3S,5S,8R,9S,10S,13S,14S,16S,17R)-3-hydroxy-10,13-dimethyl-2-morpholin-4-yl-16-(1-prop-2-enylpyrrolidin-1-ium-1-yl)-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl] acetate;bromide
InChI InChI=1S/C32H53N2O4.BrH/c1-5-14-34(15-6-7-16-34)28-20-26-24-9-8-23-19-29(36)27(33-12-17-37-18-13-33)21-32(23,4)25(24)10-11-31(26,3)30(28)38-22(2)35;/h5,23-30,36H,1,6-21H2,2-4H3;1H/q+1;/p-1/t23-,24+,25-,26-,27-,28-,29-,30-,31-,32-;/m0./s1
InChI Key OYTJKRAYGYRUJK-FMCCZJBLSA-M
MDL Number MFCD00867768
Molecular Formula C32H53BrN2O4
Molecular Weight 609.6782
SMILES C=CC[N@@+]1([C@H]5C[C@@]4([H])[C@]3([H])CC[C@@]2([H])C[C@H](O)[C@@H](N6CCOCC6)C[C@@](C)2[C@]([H])3CC[C@@](C)4[C@H]5OC(C)=O)CCCC1.[Br-]
UNII I65MW4OFHZ
Synonyms
1-(17-(acetoyl)-3-hydroxy-2-(4-morpholinyl)androstan-16-yl)-1-(2-propenyl)pyrrolidinium, Esmeron, Esmerone, ORG 9426, ORG-9426, ORG9426, pyrrolidinium, 1-((2beta,3alpha,5alpha,16beta,17beta)-17-(acetyloxy)-3-hydroxy-2-(4-morpholinyl)androstan-16-yl)-1-(2-propenyl)-, bromide, rocuronium, rocuronium bromide, Zemuron, ROCURONIUM BROMIDE, 119302-91-9, Zemuron, Esmeron, Rocuronium (Bromide), UNII-I65MW4OFHZ, Org-9426, I65MW4OFHZ, CHEBI:8885, ORG 9426, 1-Allyl-1-(3alpha,17beta-dihydroxy-2beta-morpholino-5alpha-androstan-16beta-yl)pyrrolidinium bromide, 17-acetate, 1-((2S,3S,5S,8R,9S,10S,13S,14S,16S,17R)-17-acetoxy-3-hydroxy-10,13-dimethyl-2-morpholinohexadecahydro-1H-cyclopenta[a]phenanthren-16-yl)-1-allylpyrrolidin-1-ium bromide, Pyrrolidinium, 1-((2beta,3alpha,5alpha,16beta,17beta)-17-(acetyloxy)-3-hydroxy-2-(4-morpholinyl)androstan-16-yl)-1-(2-propenyl)-, bromide, NCGC00167433-01, org9426, Eslax, Rocuroium Bromide, Rocuronium-bromide, Rocuroniun bromide, Pyrrolidinium, 1-[(2beta,3alpha,5alpha,16beta,17beta)-17-(acetyloxy)-3-hydroxy-2-(4-morpholinyl)androstan-16-yl]-1-(2-propenyl)-, bromide, Zemuron (TN), BROMOROCURONIUM, PubChem15778, Rocuronium bromide [USAN:USP:INN:BAN], DSSTox_CID_3566, AC1L9B0Y, DSSTox_RID_77083, DSSTox_GSID_23566, SCHEMBL41320, cc-624, CHEMBL1200648, DTXSID7023566, OYTJKRAYGYRUJK-FMCCZJBLSA-M, Tox21_112437, CR-015, CR0018, Rocuronium bromide (JAN/USAN/INN), s1397, AKOS025149635, AC-2004, API0024407, CS-1467, 111GE014, AN-14416, AS-13323, BC004036, BC222603, CC-34280, HY-17440, SC-21811, BCP0726000028, CAS-119302-91-9, R0099, ST24049126, D00765, W-5167, C-23335, Q-101010, Rocuronium bromide, >=98% (perchloric acid titration), Rocuronium bromide, European Pharmacopoeia (EP) Reference Standard, Rocuronium bromide, United States Pharmacopeia (USP) Reference Standard, Rocuronium for peak identification, European Pharmacopoeia (EP) Reference Standard, (2beta,3alpha,5alpha,16beta,17beta)-17-(acetyloxy)-3-hydroxy-2-morpholin-4-yl-16-(1-prop-2-en-1-ylpyrrolidinium-1-yl)androstane bromide, [(2S,3S,5S,8R,9S,10S,13S,14S,16S,17R)-16-(1-allylpyrrolidin-1-ium-1-yl)-3-hydroxy-10,13-dimethyl-2-morpholino-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl] acetate bromide, [(2S,3S,5S,8R,9S,10S,13S,14S,16S,17R)-3-hydroxy-10,13-dimethyl-2-morpholin-4-yl-16-(1-prop-2-enylpyrrolidin-1-ium-1-yl)-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl] acetate bromide, 1-((2S,3S,8R,9S,10S,13S,14S,16S,17R)-17-acetoxy-3-hydroxy-10,13-dimethyl-2-morpholinohexadecahydro-1H-cyclopenta[a]phenanthren-16-yl)-1-allylpyrrolidinium bromide, 1-[(2B,3A,5A,16B,17B)-17-(ACETYLOXY)-3-HYDROXY-2-(4-MORPHOLINYL)ANDROSTAN-16-YL]-1-(2-PROPENYL)PYRROLIDINIUM BROMIDE, 1-[(2beta,3alpha,5alpha,16beta,17beta)-17-acetyloxy-3-hydroxy-2-(4-morpholinyl)-androstan-16-yl]-1(2-propenyl)pyrrolidinium bromide, 1-[17B-(ACETYLOXY)-3A-HYDROXY2B-(4-MORPHOLINYL)-5A-ANDROSTAN-16B-YL]-1-(2-PROPENYL)PYRROLIDINIUM BROMIDE, 1-[17BETA-(ACETYLOXY)-3ALPHA-HYDROXY-2BETA-(4-MORPHOLINYL)-5ALPHA-ANDROSTAN-16BETA-YL]-1-(2-PROPENYL)PYRROLIDINIUM BROMIDE, 1-[17beta-acetyloxy-3alpha-hydroxy-2beta-(4-morpholinyl)-5alpha-androstan-16beta-yl]-1-(2-propenyl)pyrrolidinium bromide, 17beta-(acetyloxy)-3alpha-hydroxy-2beta-(morpholin-4-yl)-16beta-[1-(prop-2-en-1-yl)pyrrolidinium-1-yl]-5alpha-androstane, 17beta-acetoxy-16beta-(1-allylpyrrolidinium-1-yl)-3alpha-hydroxy-2beta-(morpholin-4-yl)-5alphaandrostane, Rocuronium, Esmerone, C32H53BrN2O4, C32-H53-Br-N2-O4, CID441351, Rocuronium bromide [USAN:BAN:INN], Rocuronium bromide [USAN:INN:BAN], ACN-048283, Rocuronium bromide, 98% - 100MG 100mg, D000077123, 1-(17-(acetoyl)-3-hydroxy-2-(4-morpholinyl)androstan-16-yl)-1-(2-propenyl)pyrrolidinium, 1-[17B-(ACETYLOXY)-3A-HYDROXY-2B-(4-MORPHOLINYL)-5A-ANDROSTAN-16B-YL]-1-(2-PROPENYL)PYRROLIDINIUM BROMIDE, Androstane-3,17-diol, 2-(4-morpholinyl)-16-(1-(2-propen-1-yl)-1-pyrrolidiniumyl)-, 17-acetate, (2beta,3alpha,5alpha,16beta,17beta)-, Pirrolidinio, 1-[(2?,3?,5?,16?,17?)-17-(acetiloxi)-3-hidroxi-2-(4-morfolinil)androstan-16-il]-1-(2-propenil)-, bromuro, Pyrrolidinium, 1-[(2,3a,5a,16,17)-17-(acetyloxy)-3-hydroxy-2-(4-morpholinyl)androstan-16-yl]-1-(2-propenyl)-, bromide,

Related Research Chemicals

CERTIFICATE OF ANALYSIS
Chemical Name: Batch Number:
Chemical Structure: CAS Registry No:
Product ID:
Manufacture Date:
Storage Temperature:
Formula:
Molecular Weight:
Quantity:
Analysis Data:
Test: Result:
Conclusion: The above product meets the specifications of Angene.
Analyst:Chase
Date:
Reviewed by:Jessie
Date:
Angene International Limited